Using mirabegron and tadalafil to improve prediabetes treatment
Official title: Mirabegron and tadalafil effectiveness for treatment of prediabetes
Funded at University of Kentucky · NIH-10746813 · Data updated 2026-11-12
This study is looking at how well two medications, mirabegron and tadalafil, can help people with prediabetes improve their blood sugar levels and metabolism without needing to lose a lot of weight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project start | December 1, 2021 |
| Project end | November 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $293,760 |
| NIH project number | 5R01DK128033-03 |
| Project ID | NIH-10746813 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with prediabetes who struggle to make lifestyle changes necessary for reversing their condition.
✕Less likely to help
Patients who are not diagnosed with prediabetes or those who have already developed type 2 diabetes may not benefit from this research.
What this research studies
This research investigates the effectiveness of two medications, mirabegron and tadalafil, in treating prediabetes, a condition affecting millions of Americans. The study aims to improve glucose metabolism and insulin sensitivity without requiring significant weight loss. By activating specific pathways in the body, these medications may help convert white fat to beige fat, which is beneficial for glucose management. Participants will be monitored for changes in their glucose tolerance and overall metabolic health.
Why it matters
Potential benefit: If successful, this research could provide a new medication-based approach to prevent the progression of prediabetes to type 2 diabetes.
How similar studies have gone: Previous studies have shown promising results using similar approaches with mirabegron and tadalafil, indicating potential for success in this research.
Where this research is happening
-
University of Kentucky
Lexington, United States Active
Researchers
- Principal investigator: Kern, Philip a — University of Kentucky
- Study coordinator: Kern, Philip a
Related research
Other NIH-funded projects on the same topics.
-
Alzheimer’s and dementia risk in people with prediabetes or type 2 diabetes
This grant aims to understand why some older adults with prediabetes or type 2 diabetes develop memory problems or dementia.
-
Alzheimer’s and related dementia in older adults with prediabetes or type 2 diabetes
This grant aims to understand why cognitive problems occur in people 65 and older who have prediabetes or type 2 diabetes, using data from a long-running diabetes study to identify what drives memory and thinking decline.
-
Support for Monitoring and Remote Tracking for Prediabetes
Aimed at helping adults with prediabetes use continuous glucose monitors (CGMs) through training and support from community health workers to improve self-management and prevent progression to diabetes.
-
Effects of different exercise intensities on blood vessels and metabolism in prediabetes and diabetes
This project tests how moderate and high-intensity interval exercise affects blood vessel and fat tissue function in male and female rats with prediabetes or diabetes.
-
ONWARD: Helping teens and young adults with prediabetes and type 2 diabetes get the resources they need
A study tests easy, in-clinic and post-visit resource help for teens and young adults with type 2 diabetes to address social needs that affect their health.
-
Walking in greenspace and built environments for adults with prediabetes
This study tests whether walking in parks or green spaces, compared to built environments, improves blood sugar and stress measures in adults with prediabetes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.